UCSF

Tagged: Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG)

Research points to individualized treatments for curing TB

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

QBI pioneers a collaborative and inclusive approach to scientific discovery

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

Innovations in Regulatory Science Summit by UCSF-Stanford CERSI

Sat Jan 5, 2019 - 8:00 am to 5:00 pm

The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) is pleased to present the inaugural Innovations in Regulatory Science Summit, a gathering of leaders from academia, industry and regulatory agencies to discuss the role of regulatory science in medical product development. This event will comprise primarily of panel discussions and short research talks by CERSI investigators on ongoing collaborative research projects with FDA investigators.

The dean advocates for medication lists and pharmacist engagement in patient care

Medical errors are the third leading cause of death in the U.S., trailing cancer and heart disease. Many of those errors can be traced back to issues with medications.

Stopping cancer in its tracks

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Sali elected to National Academy of Sciences

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

Behind enemy lines

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

UCSF School of Pharmacy leads in NIH funding for 38th year

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Taking a bite out of the proteome with PhaNGS

If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

Pages